Literature DB >> 1433196

Synthesis and biological activity of 13-epi-avermectins: potent anthelmintic agents with an increased margin of safety.

T A Blizzard1, G M Margiatto, H Mrozik, W L Shoop, R A Frankshun, M H Fisher.   

Abstract

Chemical conversion of the potent anthelmintic natural products avermectin B1 (1) and avermectin B2 (3) to the corresponding 13-epi analogs (15 and 9) is described. The novel analogs retain the full potency of the natural products but are substantially safer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433196     DOI: 10.1021/jm00099a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

Review 1.  Methods for 2-Deoxyglycoside Synthesis.

Authors:  Clay S Bennett; M Carmen Galan
Journal:  Chem Rev       Date:  2018-06-28       Impact factor: 60.622

2.  Three new milbemycins from a genetically engineered strain S. avermitilis MHJ1011.

Authors:  Jun-jie Pan; Xu Wan; Hui Zhang; Zhen Chen; Jun Huang; Bo Yang; An-liang Chen; Ji-dong Wang
Journal:  J Antibiot (Tokyo)       Date:  2015-09-02       Impact factor: 2.649

3.  Stereodivergent approach to the avermectins based on "super silyl" directed aldol reactions.

Authors:  Patrick B Brady; Susumu Oda; Hisashi Yamamoto
Journal:  Org Lett       Date:  2014-07-15       Impact factor: 6.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.